Tajikistan is considered one of the high burden multidrug-resistant tuberculosis (MDR-TB) countries.

The USAID funded, KNCV led Challenge TB project (CTB), which ran from 2014 to 2019, in Tajikistan focused on improving the capacity of the healthcare system and quality of care for drug resistant-TB (DR-TB) patients via the introduction of new tools and innovations. The scaling up of new treatment regimens for DR-TB is progressing well and brings hope to those patients with DR-TB. Advanced technologies designed for drug management are now significantly improving patients centered care in Tajikistan.

The CTB-supported countries jointly achieved the following results during the five-year project period:
– 7.3% reduction of the TB incidence rate above the global average of 6.3%
– 85% treatment success rate with more than ten countries above 90%
– 10.2 million people successfully treated 275,000 people initiated on treatment for MDR-TB
– Provision of ART for 86% of people infected with both TB and HIV

KNCV also supports the Ministry of Health in Tajikistan in strengthening the capacity of TB facilities. Improvements in human resource management together with an update of HR policy for TB services promoted better quality of services within the existing resources.

Country representative: Mavluda Makhmudova

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us


De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.